Carmen Roch

Dr. Carmen Roch

Interdisciplinary Center of Palliative Medicine, UKW, Würzburg, Bavaria, Germany
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in European Journal of Cardiovascular Nursing
Verified
Journal Article
Closed access
PDF file
CRCarmen Roch
Carmen Roch
JPJohanna Palzer
Johanna Palzer
TZTeresa Zetzl
Teresa Zetzl
SSStefan Störk
Stefan Störk
SFStefan Frantz
Stefan Frantz
BOBirgitt van Oorschot
Birgitt van Oorschot
Aim: The aim of this study was to evaluate the suitability and comprehensibility of the integrated palliative care outcome scale for the evaluation of palliative care needs in patients with heart failure. Methods and results: This cross-sectional study investigated 100 heart failure patients (40 women, 60 men; median age 79 years) within the first few days of their hospitalisation by applying the integrated palliative care outcome scale (3-day recall period) and two additional self-developed questions about the suitability and comprehensibility of the integrated palliative care outcome scale. Clinically relevant somatic and psycho-emotional symptoms were reported very frequently (approximately 75% each), followed by communicational needs or practical issues. Ninety-five per cent of patients thought the integrated palliative care outcome scale very easy to understand, and 91% judged the integrated palliative care outcome scale suitable to assess palliative care needs. Conclusion: The integrated palliative care outcome scale was well accepted by hospitalised patients with heart failure and identified a high burden of both physical and psycho-emotional symptoms. Screening for palliative care has to consider patients and their relatives alike, and should be part of a comprehensive care concept jointly integrated into clinical routine by primary and specialised palliative care teams.

1 October 2021 in JCO Oncology Practice
Verified
Journal Article
Closed access
CRCarmen Roch
Carmen Roch
MHMaria Heckel
Maria Heckel
BOBirgitt van Oorschot
Birgitt van Oorschot
BABernd Alt-Epping
Bernd Alt-Epping
MTMitra Tewes
Mitra Tewes
PURPOSE: Guidelines recommend several screening tools to identify patients with complex palliative needs. This diversity and lack of structural recommendations offer a wide scope for implementing screening. Against this background, the current status of implementation at German Comprehensive Cancer Centers (CCCs) funded by the German Cancer Aid has not yet been investigated. METHODS: e-mail survey of the 17 hospital sites of the 13 CCCs. The questionnaire asked for structural characteristics of the centers as well as preconditions of the screening process. Structurally established screening procedures (one item) and standardized workflows, modes of performance, screening tools (four items), modes of training how to screen, and responsibilities (two items) were assessed. RESULTS: In a 2-month period, 15 hospital sites responded; seven hospital sites conducted a palliative care needs (PCN) screening. Only one hospital site carried out PCN screening in almost all oncology departments, but only with the distress thermometer. Other hospital sites determined palliative needs by assessing physical symptoms using the Integrated Palliative Care Outcome Scale or the Minimal Documentation System, and two hospital sites combined tools to determine both physical and psychological stress. The type of screening varied from paper-pencil–based to tablet computer–based documentation. The main barriers to implementation were identified as a lack of human resources and a lack of structural conditions. CONCLUSION: There is a lack of consensus among palliative care specialists and oncologists in the CCCs supported by the German Cancer Aid in PCN screening as well as of structured guidelines and the professional association. Structural requirements should be adapted to these needs, which include both technical and human resources. A combined psycho-oncologic and palliative care screening might help to formulate best practice recommendations.

3 May 2022 in BMC Palliative Care
Verified
Journal Article
Open access
PDF file
MSManuela Schallenburger
Manuela Schallenburger
MRMarie Christine Reuters
Marie Christine Reuters
JSJacqueline Schwartz
Jacqueline Schwartz
MFMarius Fischer
Marius Fischer
CRCarmen Roch
Carmen Roch
MNMartin Neukirchen
Martin Neukirchen
Background: The SARS-CoV-2 pandemic has presented major challenges to the health system. Despite high acute case numbers, patients without Covid-19 still need to be cared for. Due to the severity of the disease and a possible stressful overall situation, patients with palliative care needs also require comprehensive care during pandemic times. In addition to specialized palliative care facilities, this also takes place in non palliative care wards. In order to ensure this general palliative care also in pandemic times, the experience of the staff should be used. The aim of this paper is to examine challenges and possible solutions for general palliative care inpatients in relation to the care of seriously ill and dying patients and their relatives. Methods: Qualitative semi-structured focus groups were conducted online for the study. Participants were staff from intensive care or isolation wards or from units where vulnerable patients (e.g. with cognitive impairment) are cared for. The focus groups were recorded and subsequently transcribed. The data material was analysed with the content structuring content analysis according to Kuckartz. Results: Five focus groups with four to eight health care professionals with various backgrounds were conducted. Fifteen main categories with two to eight subcategories were identified. Based on frequency and the importance expressed by the focus groups, six categories were extracted as central aspects: visiting regulations, communication with relatives, hygiene measures, cooperation, determination of the patients will and the possibility to say good bye. Conclusion: The pandemic situation produced several challenges needing specific solutions in order to manage the care of seriously ill and dying patients. Especially visiting needs regulation to prevent social isolation and dying alone. Finding alternative communication ways as well as interprofessional and interdisciplinary cooperation is a precondition for individualised care of seriously ill and dying patients and their relatives. Measures preventing infections should be transparently communicated in hospitals.

12 January 2025 in Journal of Geriatric Oncology
Verified
Journal Article
Open access
MHMiriam Hüttmeyer
Miriam Hüttmeyer
KTKathrin Tatschner
Kathrin Tatschner
EJElisabeth Jentschke
Elisabeth Jentschke
CRCarmen Roch
Carmen Roch
BDBarbara Deschler-Baier
Barbara Deschler-Baier

15 June 2024 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
JGJan Gärtner
Jan Gärtner
CBChristopher Boehlke
Christopher Boehlke
Gudrun Marie Ilse KreyeGudrun Marie Ilse Kreye
Gudrun Marie Ilse Kreye
TFTanja Fusi-Schmidhauser
Tanja Fusi-Schmidhauser
EMEvelyn Mueller
Evelyn Mueller
CRCarmen Roch
Carmen Roch
Purpose: We assumed that in Palliative Care, even in common clinical situations, the choice of drugs differs substantially between physicians. Therefore, we assessed the practice of pharmaceutical treatment choices of physicians for cancer pain and opioid-induced nausea and vomiting (OINV) and the rationale for their choices. Methods: An online survey was conducted with physicians covering the following domains: i) Cancer pain therapy: non-opioids in addition to opioids: choice of drug ii) prevention of OINV: choice of drug and mode of application. Current guidelines concerning cancer pain therapy and prevention of OINV were compared. Results: Two-hundred-forty European physicians responded to our survey. i) Use of non-opioids in addition to opioids for the treatment of cancer pain: Only 1.3% (n = 3) of respondents never used an additional non-opioid. Others mostly used: dipyrone/metamizole (49.2%, n = 118), paracetamol/acetaminophen (34.2%, n = 82), ibuprofen / other NSAIDs (11.3%, n = 27), specific Cox2-inhibitors (2.1%, n = 5), Aspirin (0.4%, n = 1), no answer (2.9%, n = 7). ii) Antiemetics to prevent OINV: The drugs of choice were metoclopramide (58.3%, n = 140), haloperidol (26.3%, n = 63), 5-HT3 antagonists (9.6%, n = 23), antihistamines (1.3%, n = 3) and other (2.9%, n = 7); no answer (1.7%, n = 4). Most respondents prescribed the substances on-demand (59.6%, n = 143) while others (36.3%, n = 87) provided them as around the clock medication. Over both domains, most physicians answered that their choices were not based on solid evidence from randomized controlled trials (RCTs). Guidelines were inconsistent regarding if and what non-opioid to use for cancer pain and recommend anti-dopaminergic drugs for prevention or treatment of OINV. Conclusions: Physician’s practice in palliative care for the treatment of cancer pain and OINV differed substantially. Respondents expressed the lack of high-quality evidence- based information from RCTs. We call for evidence from methodologically high-quality RCTs to be available to inform physicians about the benefits and harms of pharmacological treatments for common symptoms in palliative care.

31 May 2025 in BMC Palliative Care
Verified
Journal Article
Open access
PDF file
PHPhilipp Helmer
Philipp Helmer
JGJessica Glück
Jessica Glück
AAAnastasios Anastasiadis
Anastasios Anastasiadis
FRFlorian Rumpf
Florian Rumpf
SHSebastian Hottenrott
Sebastian Hottenrott
MSMichael Sammeth
Michael Sammeth
Background: Continuous monitoring of vital parameters using wearable devices offers potential benefits in palliative care, such as early detection of clinical deterioration and improving symptom management. However, evidence supporting their feasibility and utility in hospitalized palliative care patients remains scarce. Methods: This prospective pilot study aimed to evaluate the feasibility of continuous vital sign monitoring in hospitalized palliative care patients using wrist-worn and chest-wall devices. The study was conducted from October 2023 to November 2024 and included hospitalized patients at a university hospital. Eligible participants were required to provide written informed consent. Patients were monitored for up to 30 days or until discharge or death. Data acquisition focused on the quantity and quality of recorded parameters, including heart rate, respiratory rate, and oxygen saturation, as well as advanced hemodynamic variables. Challenges in recruitment, device performance, and data reliability were assessed. Results: A total of 275 patients were screened, with 263 excluded for not meeting eligibility criteria. Of the nine patients who provided written informed consent, two withdrew consent before study interventions, leaving seven participants. Among these, one patient completed the maximum study duration, three were discharged to outpatient care, and three died during hospitalization. Wrist-worn devices yielded valid data for 61.5% of the monitored time (median: 57.6%; range: 20.1–78.3%), while chest-wall devices achieved 55.2% (median: 62.3%; range: 3.6–100%). Heart rate and respiratory rate showed excellent reliability (> 99% data availability), whereas oxygen saturation exhibited poor performance (45.1%). The interval between the last recorded device measurement and time of death ranged from 0 to 25 min. Recruitment challenges, including strict consent requirements, resulted in premature study termination, as achieving the target sample size of 25 patients was deemed unfeasible. Conclusion: This pilot study demonstrates the potential of continuous monitoring technologies in palliative care, but inconsistent data availability limits the ability to recommend their routine use at this stage. Despite these challenges, the promising results highlight the need for further studies to improve device reliability and explore the broader applicability of this technology in palliative care settings.